Analyst Ratings for BioMarin Pharmaceutical Inc. (bmrn)
bmrn Rating Summary
bmrn Price Target Summary
- Highest: $124.00 (Morgan Stanley)
- Lowest: $60.00 (H.C. Wainwright)
- Average: $89.92
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$89.92 (+62.3%)
* Over Last 12-Mos
Rating Score: 7.1 / 10
Percentile Rank: 75%
Avg. $ Target:
$89.92 (+62.3%)
* Over Last 12-Mos
Rating Score: 7.1 / 10
Percentile Rank: 75%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 10/12/2026 | Raymond James | Chris Raymond | Upgrade | Strong Buy (Outperform) |
109.00 (N/A) |
54.80 (55.39) |
1.08% | Details |
| 8/18/2026 | BMO Capital » Updated 9/16/2026 |
David Lebowitz | New Coverage | Outperform (N/A) |
97.00 (98.00) |
66.64 (55.39) |
-16.88% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
